Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV polyvalent immunoglobulin (Tegeline) for DRESS syndrome
2006-005748-10Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Mar 2007
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of polyvalent human immunoglobulin in drug hypersensitivity syndrome (DRESS), sponsored by Rouen University Hospital. Primary endpoints: Rapid resolution of visceral involvement, Resolution of fever and 2 more. Started Mar 2007; status: active.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
drug hypersensitivity syndrome (DRESS)
Beyond the preview
Go deeper on 2006-005748-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005748-10.